Table 2.
Characteristic | |
SSN(−) |
|
SSN(+) |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Sample size, n (%) | Mean | SD | Min. | Max. | Sample size, n (%) | Mean | S.D. | Min. | Max. | |
Age (years) | N.A. | 53.9 | 14.2 | 16 | 93 | N.A. | 48.7 | 12 | 20 | 75 |
FG (mg/dL) | 93.2 | 24.5 | 47 | 226 | 88.2 | 18.3 | 58 | 194 | ||
CHOL (mg/dL)a | 219.6 | 41.1 | 140 | 354 | 208.9 | 39 | 129 | 341 | ||
TG (mg/dL)b | 173.2 | 91.8 | 46 | 663 | 148.4 | 104.2 | 14 | 801 | ||
CHOL % (CHOL/HDL) | 3.9 | 1.1 | 1.8 | 8.6 | 3.8 | 1.5 | 1.9 | 12.7 | ||
LDL (mg/dL) | 126.8 | 33.3 | 55 | 238 | 120.1 | 37 | 0.9 | 214 | ||
TSH (mIU/L) | 2.1 | 1.2 | 0.1 | 6.37 | 2.3 | 1.5 | 0.3 | 12.8 | ||
HBsAb(+), n (%) | 104 (52) | N.A. | 39 (38) | N.A. | ||||||
HBsAg(+), n (%) | 18 (9) | 8 (8) |
Two-sample t-test, with p-value=0.0388, 0.03, respectively.
CHOL, cholesterol; CHOL% (CHOL/HDL), total-cholesterol-to-HDL cholesterol ratio; FG, fasting glucose; HBsAb, hepatitis B surface antibody; HBsAg, hepatitis B surface antigen; LDL, low-density lipoprotein; SSN, social security number; Min., minimum; Max., maximum; N.A., not applicable; SD, standard deviation; TG, triglycerides; TSH, thyroid-stimulating hormone.